FDA grants expanded approval for Bristol Myers Squibb anemia therapy - NJBIZ

“The approval of Reblozyl in the first-line treatment of anemia for patients with lower-risk MDS represents a crucial step in making transfusion independence possible for more patients," said Tracey Iraca, executive director of the MDS Foundation.

U.S. FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi® for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

Bristol Myers (BMY) Gets FDA Nod for Reblozyl Label Expansion

Bristol Myers (BMY) Gets FDA Nod for Reblozyl Label Expansion

U.S. FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi® for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

Making a list - NJBIZ

WCRE exclusive in acquiring Marlton office property - NJBIZ

Bristol Myers Squibb - U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag™ (nivolumab and relatlimab-rmbw), as Treatment for Patients with Unresectable or Metastatic Melanoma

Bristol Myers Squibb Stock Falls After Delay to Gene Therapy Drug Approval - Barron's

Bristol Myers Squibb - Recent News & Activity

PEEK Properties nears completion of East Orange Class A apartments - NJBIZ

Latest Pharma News and Updates Novartis, Gilead, BMS, AstraZeneca

American Dream's luxury retail wing opens this September - NJBIZ